Ann: Imugene onCARlytics Doses First Patient in IV Combination, page-113

Its the cost of running these trials which translates into a SP drop. Its guaranteed to to drop the SP because of the cost of trials.

Today is a pretty close example of every announcement which was ' the first dosed' - this guarantees a cost for IMU and its 'bank account' - today as a guess based on open price before ' the red dump' its looking like this trial could be worth 30-50 million $ as a cost, the SP as a close now reflects something close to this.

TB, chow mein ?
- its just theory but its played out the same way again.